logo here
 
print report go to library previous page
 

Lipoprotein Checklist:
Intermediate-density lipoproteins (IDL)


After a meal, our bodies are meant to clear the by-products of eating from our blood within 4–6 hours. However, approximately 20% of people with coronary plaque have after-eating by-products, called post-prandial lipoproteins, or PPLs, linger for 24 hours or longer. When PPLs linger, they exert damaging effects on vascular structures. PPL particles insert themselves into atherosclerotic plaque and fuel growth, and cause atherosclerosis through other pathways.

  • PPLs block natural artery relaxing agents, nitric oxide and endothelin, and thereby induce endothelial dysfunction (abnormal artery constriction), a fundamental process in atherosclerotic plaque formation.
  • PPLs trigger increased blood levels of cellular adhesion molecules (CAM) like intracellular adhesion molecule-1, vascular cellular adhesion molecule VCAM-1, and E-selectin. When blood levels of CAMs are increased, inflammatory white blood cells adhere more readily to the artery wall and gain entry, leading to atherosclerotic plaque formation.
  • PPLs activate blood clotting via increases in clotting factors VII and reduction of PAI-1, an inhibitor of clotting.
  • PPLs trigger formation of a cascade of other abnormal lipoprotein particles that are potent causes of heart and vascular disease, e.g., small LDL particles.

Because triglycerides are a principal ingredient in PPLs, elevated fasting triglycerides can serve as an indirect index of increased PPLs. If triglycerides are ≥100 mg/dl, PPLs are likely to be present. But fasting triglycerides are not foolproof, and substantial PPL excess can still occur with triglyceride levels of <100 mg/dl.

The best method to assess whether PPLs are present is to measure intermediate-density lipoproteins (IDL) in fasting blood. (Direct PPL measurement is a research tool unavailable to use.) A normal amount of IDL is none—none whatsoever should be detected in fasting blood. If present, IDL triggers atherosclerotic plaque growth. It is also a potent cause of abdominal and thoracic aneurysms of the aorta. IDL has also been shown to heighten the likelihood of pure soft plaque in carotid arteries, the sort that easily fragment, release debris, and cause strokes.

How to Manage and Reduce IDL


Want to read the rest of this Track Your Plaque Special Report?

Already a member? CLICK HERE to log-in.

Want to become a member? CLICK HERE

Want to learn more about the benefits of membership? CLICK HERE


Copyright 2007, Track Your Plaque.